←
Future Fields983 posts
Future Fields avatar✓

Future Fields ✓

@futurefieldsHQ

Using fruit flies 🪰 to make recombinant proteins. 🧬🧫 Helping scientists change the world.

◷ Joined April 2018▧ 502 Photos and videos
Future Fields avatar
Future Fields@futurefieldsHQ·Apr 30

Your strategic partner in breaking #biomanufacturing bottlenecks and rescuing protein projects 👨‍🔬 Erik (VP of Technical Operations) and Karina (Head of Quality) walks us through the process of protein manufacturing with the EntoEngine™ 🪰 and Instar 1.0 🏭

1:34
Future Fields avatar
Future Fields@futurefieldsHQ·Nov 16

What a great night at WiSER’s 2026 Annual Industry Mixer! 👩‍🔬 We had so many great conversations with students, industry peers, and organizations championing women in STEM. Thank you to the WiSER team for bringing everyone together! @wiseredmonton

Post attachment
Future Fields avatar
Future Fields@futurefieldsHQ·Nov 12

Sourcing complex diagnostic antigens and enzymes shouldn’t put your commercial timelines at risk. Our latest article explores why complex IVD reagents are difficult to source and how to build a more resilient supply chain. 📦 Read the breakdown 👉 bit.ly/4sWjxng

Post attachment
Future Fields avatar
Future Fields@futurefieldsHQ·Nov 5

Why are diagnostic antigens and enzymes a commercial bottleneck? Standard hosts like E. coli can struggle with complex antigens and enzymes that need precise folding, multi-subunit assembly, and PTMs. ➡️ Explore our latest article: bit.ly/4iWqtwZ

0:10
Future Fields avatar
Future Fields@futurefieldsHQ·Oct 29

Part 2 of our Crop Trait article on Herbicide Tolerance (HT) traits and enzymes is live! Discover how trait developers are overcoming recombinant expression, assembly, and purification bottlenecks across major commercial HT enzyme classes. Read here 👉 hubs.li/Q04CGZt70

Future Fields avatar
Future Fields@futurefieldsHQ·Oct 27

How is reagent volatility shaping IVD? While antibodies scale, complex antigens and enzymes hit severe bottlenecks. 🧬 Learn how to build a resilient supply chain 👉 hubs.li/Q04CppSd0

Future Fields avatar
Future Fields@futurefieldsHQ·Oct 22

Expressing a herbicide tolerance trait is only half the battle, producing enough active protein is where pipelines stall.  Our article explores: 🟢 Plant extraction limits 🟢 HT trait roles & tolerance pathways 🟢 Biomanufacturing hurdles ➡️ Read now: hubs.li/Q04BYYQR0

Future Fields avatar
Future Fields@futurefieldsHQ·Oct 21

📢 We’re #hiring a hands-on Protein Biochemistry Technician to run small-scale protein expression and analytics. If you thrive in a fast-paced lab environment and enjoy combining bench work with smart troubleshooting, this role is for you. Apply now 👉 hubs.ly/Q04BPQHD0

Future Fields avatar
Future Fields@futurefieldsHQ·Oct 20

Can your expression host deliver active, correctly folded proteins for regulatory studies? Part 2 of our crop trait series breaks down major herbicide tolerance enzyme classes and surrogate protein supply bottlenecks. 👉 Read it here: hubs.li/Q04BF6xC0

Post attachment
Zero Point Cryogenics avatar
⟳ Future Fields retweeted
Zero Point Cryogenics@cryoZP·Oct 9

There is no step-by-step guide for building a deep tech company, but sharing lessons learned can make the journey clearer for everyone. 💡 This week at #EdmontonStartupWeek, our Co-Founder & CTO, Dr. John P. Davis, took the stage at @EdmontonUnltd for the "Building Deep Tech Companies" panel. Alongside fellow founders and ecosystem leaders, Dr. Ryan Tucker of @G2VOptics and Jalene Anderson-Baron of @futurefieldsHQ, John shared real-world insights on what it takes to bring breakthrough research out of the lab and scale a deep-tech company from right here in Alberta. A big thank you to moderator Tiffany Linke-Boyko of @flyingfishvc! Events like this create valuable spaces for founders, innovators, and big thinkers to come together, exchange wisdom, and empower the next generation of entrepreneurs.🔬 #DeepTech #EdmontonStartupWeek #YEGtech #ColderForLonger #QuantumComputing #Cryogenics #ZeroPointCryogenics #ZPC #MadeInCanada

Post attachment
Future Fields avatar
Future Fields@futurefieldsHQ·Oct 15

What if you could source complex recombinant antigens and enzymes that aren’t available anywhere else? Our custom expression platform addresses:  🔹 Inclusion Body & Solubility Challenges 🔹 Glycosylation 🔹 Scale-up Bottlenecks Learn more 👉 bit.ly/4hD0KrG

Future Fields avatar
Future Fields@futurefieldsHQ·Oct 13

See you at #AMP2026! 👋 Reach out to Jeremy to learn how our Drosophila-based EntoEngine® platform addresses challenges in producing proteins used in molecular diagnostic assays. 🪰

Post attachment
Future Fields avatar
Future Fields@futurefieldsHQ·Oct 8

Say hello to our Sustainability Committee! 🌎🧪 This crew is always finding new ways to cut waste, optimize the lab, and keep daily operations sustainable.  Check out how we put sustainability first 👉 bit.ly/479VHKx

Post attachmentPost attachment
Future Fields avatar
Future Fields@futurefieldsHQ·Oct 6

Expressing complex diagnostic targets shouldn’t stall due to improper folding, low yields, or scaling costs.  The EntoEngine® solves these problems by delivering native-like, complex diagnostic assets at scale without traditional bottlenecks. 👉 bit.ly/4rOxZgs

Post attachment
Future Fields avatar
Future Fields@futurefieldsHQ·Sep 29

That’s a wrap on Sustain Labs: Beyond the Bench! We couldn't have asked for a better crowd! A big thank you to our moderator and panelists for sharing their honest experiences with us. We’re excited to keep driving sustainability forward together! 🚀 💚

Post attachmentPost attachmentPost attachment